Increased UGT1A3 and UGT1A7 Expression is Associated with Pancreatic Cancer

  • Yilmaz, Latif (Department of General Surgery, Faculty of Medicine, University of Gaziantep) ;
  • Borazan, Ersin (Department of General Surgery, Faculty of Medicine, University of Gaziantep) ;
  • Aytekin, Turkan (Department of Biology, Faculty of Arts and Sciences, Gaziantep University) ;
  • Baskonus, Ilyas (Department of General Surgery, Faculty of Medicine, University of Gaziantep) ;
  • Aytekin, Alper (Department of General Surgery, Faculty of Medicine, University of Gaziantep) ;
  • Oztuzcu, Serdar (Department of Medical Biology, Faculty of Medicine, Gaziantep University) ;
  • Bozdag, Zehra (Department of Pathology, Faculty of Medicine, Gaziantep University) ;
  • Balik, Ahmet (Department of General Surgery, Faculty of Medicine, University of Gaziantep)
  • Published : 2015.03.09


UGT1A play important roles in the glucuronidation of a variety of endogenous and exogenous compounds. UGT1A isoforms are expressed tissue specifically. The aim of this study was to examine the relationship between UGT1A3 and UGT1A7 mRNA expression and pancreatic cancer. Paired healthy and tumor tissue samples of 43 patients with pancreatic cancer were included in this study. UGT1A3 and UGT1A7 mRNA expressions were analyzed by real time-PCR. In the result of study, UGT1A3 and UGT1A7 mRNA expressions were significantly higher in tumor tissue than normal tissue of pancreatic cancer patients (p<0.05). In addition, high mRNA expression of UGT1A3 and UGT1A7 was significantly associated with larger tumor size (p<0.05). The data suggested that UGT1A3 and UGT1A7 may play roles in the progression of pancreatic cancer. Consequently, UGT1A3 and UGT1A7 are potential prognostic indicators.


UGT1A3;UGT1A7;expression;pancreatic cancer


  1. Afsar CU, Gunaldi M, Kum P, et al (2014). Pancreatic carcinoma, thrombosis and mean platelet volume:single center experience from the southeast region of Turkey. Asian Pac J Cancer Prev, 15, 9143-6.
  2. Bayoglu IV, Varol U, Yildiz I, et al (2014). Second-line capecitabine and oxaliplatin combination for gemcitabineresistant advanced pancreatic cancer. Asian Pac J Cancer Prev, 15, 7119-23.
  3. Canyilmaz E, Serdar L, Uslu GH, et al (2013). Evaluation of prognostic factors and survival results in pancreatic carcinomas in Turkey. Asian Pac J Cancer Prev, 14, 6573-8.
  4. Chen WQ, Liang D, Zhang SW, et al (2013). Pancreatic cancer incidence and mortality patterns in china, 2009. Asian Pac J Cancer Prev, 14, 7321-4.
  5. Finel M, Li X, Gardner-Stephen D, et al (2005). Human UDPGlucuronosyltransferase 1A5: identification, expression, and activity. J Pharmacol Exp Ther, 315, 1143-9.
  6. Gaganis P, Miners JO, Brennan JS, Thomas A, Knights KM (2007). Human renal cortical and medullary UDPglucuronosyltransferases (UGTs): immunohistochemical localization of UGT2B7 and UGT1A enzymes and kinetic characterization of S-naproxen glucuronidation. J Pharmacol Exp Ther, 323, 422-30.
  7. Gong QH, Cho JW, Huang T, et al (2001). Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics, 11, 357-68.
  8. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE (2000). Structural heterogeneity at the UDPglucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics, 10, 629-44.
  9. Hanioka N, Iwabu H, Hanafusa H, Nakada S, Narimatsu S (2012). Expression and Inducibility of UDP-glucuronosyltransferase 1As in MCF-7 human breast carcinoma cells. Basic Clin Pharmacol, 110, 253-8.
  10. Huang WY, Yue L, Qiu WS, et al (2009). Prognostic value of CRM1 in pancreas cancer. Clin Invest Med, 32, 315-21.
  11. Izumi K, Li Y, Ishiguro H, et al (2014). Expression of UDPglucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen. Mol Carcinogen, 53, 314-24.
  12. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
  13. Liu SZ, Chen WQ, Wang N, et al (2014). Dietary factors and risk of pancreatic cancer: a multi-centre case-control study in China. Asian Pac J Cancer Prev, 14,7947-50.
  14. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-8.
  15. Nakamura A, Nakajima M, Yamanaka H, Fujiwara R, Yokoi T (2008). Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines. Drug Metab Dispos, 36, 1461-4.
  16. Ockenga J, Vogel A, Teich N, et al (2003). UDP Glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterol, 124, 1802-8.
  17. Peters WH, te Morsche RH, Roelofs HM (2003). Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with gilbert's syndrome. J Hepatol, 38, 3-8.
  18. Piepoli A, Gentile A, Valvano MR, et al (2006). Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients. World J Gastroenterol, 12, 6343-8.
  19. Starlard-Davenport A, Lyn-Cook B, Radominska-Pandya A (2008). Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues. Steroids, 73, 611-20.
  20. Strassburg CP, Barut A, Obermayer-Straub P, et al (2001). Identification of cyclosporine A and tacrolimus glucuronidation in human liver and the extrahepatic gastrointestinal tract by a differentially expressed UDPglucuronosyltransferase: UGT2B7. J Hepatol, 34, 865-72.
  21. Strassburg CP, Kneip S, Topp J, et al (2000). Polymorphic gene expression and interindividual variation of UDPglucuronosyltransferase activity in human small intestine. J Biol Chem, 275, 36164-71.
  22. Strassburg CP, Manns MP, Tukey RH (1998). Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J Biol Chem, 273, 8719-26.
  23. Strassburg CP, Nguyen N, Manns MP, Tukey RH (1998b). Polymorphic Expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol Pharmacol, 54, 647-54.
  24. Strassburg CP, Nguyen N, Manns MP, Tukey RH (1999b). UDPglucuronosyltransferase activity in human liver and colon. Gastroenterol, 116, 149-60.
  25. Strassburg CP, Oldhafer K, Manns MP, Tukey RH (1997). Differential expression of the UGT1A locus in human liver, biliary and gastric tissue. Identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol, 52, 212-20.
  26. Strassburg CP, Strassburg A, Kneip S, et al (2002b). Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut, 50, 259-65.
  27. Strassburg CP, Strassburg A, Nguyen N, et al (1999a). Regulation and function of family 1 and family 2 UDPglucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus. Biochem J, 338, 489-98.
  28. Strassburg CP, Vogel A, Kneip S, Tukey RH, Manns MP (2002a). Polymorphisms of the human UDP glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut, 50, 851-6.
  29. Tang KS, Chiu HF, Chen HH, et al (2005). Link between colorectal cancer and polymorphisms in the uridinediphosphoglucuronosyltransferase 1A7 and 1A1 genes. World J Gastroenterol, 11, 3250-4.
  30. Tukey RH, Strassburg CP (2000). Human UDPglucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol, 40, 581-616.
  31. Verlaan M, Drenth JPH, Truninger K, et al (2005). Polymorphisms of UDPglucuronosyltransferase 1A7 are not involved in pancreatic diseases. J Med Genet, 42, 62.
  32. Vogel A, Kneip S, Barut A, et al (2001). Genetic link of hepatocellular carcinoma with polymorphisms of the UDPGlucuronosyltransferase UGT1A7 Gene. Gastroenterol, 121, 1136-44.
  33. Wang M, Qi YY, Chen S, et al (2012). Expression of UDPglucuronosyltransferase 1A, nuclear factor erythroid-E2-related factor 2 and Kelch-like ECH-associated protein 1 in colonic mucosa, adenoma and adenocarcinoma tissue. Oncol Lett, 4, 925-30.
  34. Wang WJ, Qin SH, Zhang JW, et al (2014). Combination doxorubicin and interferon-${\alpha}$ therapy stimulates immunogenicity of murine pancreatic cancer Panc02 cells via up-regulation of NKG2D ligands and MHC class I. Asian Pac J Cancer Prev, 15, 9667-72.
  35. Wang M, Sun DF, Wang S, et al (2013). Polymorphic expression of UDP-glucuronosyltransferase UGTlA gene in human colorectal cancer. Plos One, 8, 57045.
  36. Zahir S, Arjmand A, Kargar S, et al (2013). Incidence and trends of malignant and benign pancreatic lesions in Yazd, Iran between 2001 and 2011. Asian Pac J Cancer Prev, 14, 2631-5.